Market Research Future has a Half Cooked Research report on analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the 3D Bioprinting Market.
3D Bioprinting Market – Competitive Analysis & News
Key market contributors are Stratasys Ltd. (U.S.), ORGANOVO HOLDINGS, INC. (U.S.), Aspect Biosystems Ltd. (Canada), FATHOM (U.S.), CELLINK AB (Sweden), Bio3D Technologies (Singapore), Materialise (U.S.), Allevi (U.S.), and ENVISIONTEC, INC. (Germany).
The market has various research institutes whose intensive research work is bearing fruit for the healthcare. Many of them are collaborating for a better result. Poietis, a Pessac, France-based Company, has collaborated with Prometheus, to develop high-precision 3D bioprinting of tissue for skeletal regeneration.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/869 .
Different companies along with academic institutes and laboratories are investing a huge capital for 3D bioprinting research and development has supported the market growth. Key players in the market are involved in extensive R&D activities to use stem cells for bioprinting tissues, which drives the growth of this market. For instance, Materialise is one of the major player in this market. The company manufactures 3D bioprinters, and also undertakes 3D printing of anatomical models. In June 2017, Materialise improved 3D imaging and printing- clinical trials conducted in the U.S.
Additionally, in March 2017, the company announced FDA clearance for their 3D-printed patient-specific radius and ulna osteotomy guides for children. In May 2017, the company announced they would begin production of 3D bioprinter using technology-HP Jet Fusion 3D 4200.
Companies like Organovo, which are printing human tissues with the help of 3D bioprinters, developed in collaboration with Invetech, will lead us into the future of medicine. As the 3D bioprinting technology advances, synthetic body organs and artificial tissues will become a reality in future.
Moreover, Organovo Holding Inc. participated in conferences such as Cantor Fitzgerald Inaugural Healthcare Conference in 2015, in order to increase awareness regarding their current activities in the field of 3D bioprinting. The company also announced a partnership with L’Oreal in the field of hair and skin care to develop skin tissue using their NovoGen Bioprinting Platform. Therefore, the various key developments in the area of 3D bioprinting has upsurged the growth of the market.
3D Bioprinting Market – Drivers and Restraints
Improvement in healthcare has given rise to the geriatric population consequently which has become the key factor that is expected to boost the global 3D bioprinting market. Government investment in this sector has helped it gained traction. Increasing number of organ transplantation and high prevalence of chronic diseases are expected to propel the growth rate of the market. In addition, stem cell research and cosmetic industry are now adopting this new technology giving it a much-needed momentum.
However, the lack of trained professionals and stringent government regulations may impede the average market growth rate.
3D Bioprinting Market – Overview
The Global 3D Bioprinting Market is expected to experience an astounding growth with a CAGR of 25% during the forecast period (2017-2023), reports Market Research Future (MRFR). The technology has been revolutionizing the pharmaceutical scenario by bioprinting human tissues and organs since its inception. A blend of the most exceptional innovations in engineering, manufacturing, art, education, and medicine, the technology is helping a number of patients by transforming their lives.
3D Bio-Printing involves the identification of the key architectural and compositional elements of a target tissue, and then creating a design that can be utilized by a bio-printer so as to generate that tissue in a laboratory environment. The technique is driving innovation in many areas of medicine, engineering, education, and others. 3D bio-printing is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation, which is driving the market growth along with the increasing healthcare expenditure
3D Bioprinting Market – Segmentation
The Global 3D Bioprinting technology can be segmented by technology, material, application, and end-users.
Technology-wise segmentation includes electron beam melting, laser beam melting, droplet disposition, syringe extrusion, magnetic levitation, and others. Syringe extrusion is expected to hold the maximum share in the market. Meanwhile, magnetic levitation is estimated to grow with the fastest CAGR during the prognosis period. Magnetic levitation allows usage of cheap printing machine is making the segment more consumer-friendly. Sub-segments of laser beam melting are photopolymerization, stereo lithography, two-photon polymerization, and others. The droplet disposition can further be sub-segmented into inkjet printing, fused disposition methods, multi-phase jet solidification, and others.
Based on the material, the market is comprised of cells, hydrogels, extracellular matrices, fibrinogen, alginate, and others. Cells are the current rage in the market and hold the maximum share as researchers are structuring their research plans on these cells.
Application-based segmentation consists clinical, research, and others. The clinical segment has sub-segments, namely, tissue transplantation, bone grafts, vascular grafts, wound care, and others. The wound care segment has acute wounds, chronic wounds, hernia repair, and others. The research segment has regenerative medicine, personalized healthcare, 3D cell culture, and others. The last segment is expected to dominate the market and grow at a stellar pace as various market players and universities are funding researches to take the developments to an unprecedented level.
The end-user segment includes pharmaceutical & biotechnology companies, research organization, academic institutes, and others.
3D Bioprinting Market – Regional Analysis
Geographically, the market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas hold the maximum share owing to a well-structured healthcare sector and heavy investment both by the government and the private players. A large base of patient population waiting for transplantation is also a market booster. Healthcare expenditure due to a rise in disposable income and the presence of significant market players are proving to be significant contributors.
Europe is the second largest market with a cluster of developed countries such as France, Germany and the U.K. who are spending heavily on the technology and is always eager to innovate.
APAC is the fastest growing region with continuously growing population and burgeoning healthcare sector in developing countries such as China and India. According to the Indian Brand Equity Foundation in 2017, the Indian market is deemed to grow with an astonishing CAGR of 22.87% by 2020 and touch USD 280 billion.
MEA is unlikely to get a huge boost owing to the presence of several poor countries in the region. Qatar, Kuwait, Saudi Arabia, and Dubai are the few countries with advanced healthcare infrastructure and interested in research investments.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/869 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312